ConductScience.org, home

Paper35547769

Polymer chimera of stapled oncolytic peptide coupled with anti-PD-L1 peptide boosts immunotherapy of colorectal cancer.

Lu L and 12 others. Theranostics, 2022. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Polymer chimera of stapled oncolytic peptide coupled with anti-PD-L1 peptide boosts immunotherapy of colorectal cancer. Papers, record 35547769. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35547769

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Polymer chimera of stapled oncolytic peptide coupled with anti-PD-L1 peptide boosts immunotherapy of colorectal cancer.
PubMed
Journal
Theranostics
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
1.97
iCite
Revised in PubMed
2022-11-10
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lu LLu
2Zhang HHe
3Zhou YYudong
4Lin JJiayi
5Gao WWeidong
6Yang TTing
7Jin JJinmei
8Zhang LLijun
9Nagle DGDale G
10Zhang WWeidong
11Wu YYe
12Chen HHongzhuan
13Luan XXin

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
B7-H1 AntigenMajor topic
Colorectal NeoplasmsMajor topic
Animals
Mice
Cell Line, Tumor
Immune Checkpoint Inhibitors
Immunologic Factors
Immunotherapy
Matrix Metalloproteinase 2
Peptides
Polymers

Source PubMed

Download CSV of topics

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132283007Nano Codelivery of Oxaliplatin and Folinic Acid Achieves Synergistic Chemo-Immunotherapy with 5-Fluorouracil for Colorectal Cancer and Liver Metastasis.ACS Nano2020https://conductscience.org/library/papers/32283007PubMed
231413527Immunotherapy in colorectal cancer: Available clinical evidence, challenges and novel approaches.World J Gastroenterol2019https://conductscience.org/library/papers/31413527PubMed
334174350Systemic administration of polymersomal oncolytic peptide LTX-315 combining with CpG adjuvant and anti-PD-1 antibody boosts immunotherapy of melanoma.J Control Release2021https://conductscience.org/library/papers/34174350PubMed
432553783Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers.Adv Drug Deliv Rev2020https://conductscience.org/library/papers/32553783PubMed
534580473Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways.Nat Rev Clin Oncol2022https://conductscience.org/library/papers/34580473PubMed
631427820Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice.Nat Biotechnol2019https://conductscience.org/library/papers/31427820PubMed
730886395Immunotherapy in colorectal cancer: rationale, challenges and potential.Nat Rev Gastroenterol Hepatol2019https://conductscience.org/library/papers/30886395PubMed
834105277Multi-Arm PEG/Peptidomimetic Conjugate Inhibitors of DR6/APP Interaction Block Hematogenous Tumor Cell Extravasation.Adv Sci (Weinh)2021https://conductscience.org/library/papers/34105277PubMed
928163220Nano-encapsulation of a novel anti-Ran-GTPase peptide for blockade of regulator of chromosome condensation 1 (RCC1) function in MDA-MB-231 breast cancer cells.Int J Pharm2017https://conductscience.org/library/papers/28163220PubMed
1031810556Antigen processing and presentation.Int Rev Cell Mol Biol2019https://conductscience.org/library/papers/31810556PubMed
1132760014Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors.Nat Rev Clin Oncol2020https://conductscience.org/library/papers/32760014PubMed
1233995609Role of nanoparticle-mediated immunogenic cell death in cancer immunotherapy.Asian J Pharm Sci2021https://conductscience.org/library/papers/33995609PubMed
1332209603Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.J Immunother Cancer2020https://conductscience.org/library/papers/32209603PubMed
1432194854Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel.Theranostics2020https://conductscience.org/library/papers/32194854PubMed
1528555136Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives.Front Immunol2017https://conductscience.org/library/papers/28555136PubMed
1626176173Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical Data.Hum Gene Ther2015https://conductscience.org/library/papers/26176173PubMed
1730498202Non-invasive delivery strategies for biologics.Nat Rev Drug Discov2019https://conductscience.org/library/papers/30498202PubMed
1833997867A tumor extracellular pH-sensitive PD-L1 binding peptide nanoparticle for chemo-immunotherapy of cancer.J Mater Chem B2021https://conductscience.org/library/papers/33997867PubMed
1922658128Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.N Engl J Med2012https://conductscience.org/library/papers/22658128PubMed
2033098912Dendronized polymer conjugates with amplified immunogenic cell death for oncolytic immunotherapy.J Control Release2021https://conductscience.org/library/papers/33098912PubMed

See all 44 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
42609883Polymeric Nanoparticles for Precision Tumor Immunotherapy: Rational Design Strategies and Spatiotemporal Immune Activation.Int J Nanomedicine2026https://conductscience.org/library/papers/42609883PubMed
42257206Harnessing Self-Assembling Peptides on γδ T Cells to Enhance Anti-Tumor Immunity.Polym Sci Technol2026https://conductscience.org/library/papers/42257206PubMed
42118213Mechanism-Informed Machine Learning Enables Discovery of Oncolytic Peptides for Cancer Immunotherapy.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42118213PubMed
41672596Immunobiological mechanisms of action of oncolytic peptides.J Immunother Cancer2026https://conductscience.org/library/papers/41672596PubMed
40959869A Serum-Stable Antimicrobial Peptide-Based Delivery Platform for Selective Treatment of Nontargetable and Chemoresistant Tumors.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40959869PubMed
40591134Bibliometric analysis of programmed cell death and immunogenic cell death in hepatocellular carcinoma immunotherapy: global trends and future directions.Discov Oncol2025https://conductscience.org/library/papers/40591134PubMed
40336045Advances in cancer immunotherapy: historical perspectives, current developments, and future directions.Mol Cancer2025https://conductscience.org/library/papers/40336045PubMed
39882247DAMPs prognostic signature predicts tumor immunotherapy, and identifies immunosuppressive mechanism of pannexin 1 channels in pancreatic ductal adenocarcinoma.Front Immunol2024https://conductscience.org/library/papers/39882247PubMed
39653795Pseudokinase TRIB3 stabilizes SSRP1 via USP10-mediated deubiquitination to promote multiple myeloma progression.Oncogene2025https://conductscience.org/library/papers/39653795PubMed
39309492Insights into therapeutic peptides in the cancer-immunity cycle: Update and challenges.Acta Pharm Sin B2024https://conductscience.org/library/papers/39309492PubMed
37284456Nanoblock-mediated selective oncolytic polypeptide therapy for triple-negative breast cancer.Theranostics2023https://conductscience.org/library/papers/37284456PubMed
36986636Smart Polymeric Nanoparticles in Cancer Immunotherapy.Pharmaceutics2023https://conductscience.org/library/papers/36986636PubMed
36765028A biomimetic nanoplatform for customized photothermal therapy of HNSCC evaluated on patient-derived xenograft models.Int J Oral Sci2023https://conductscience.org/library/papers/36765028PubMed
36278104Functionalized Peptide-Based Nanoparticles for Targeted Cancer Nanotherapeutics: A State-of-the-Art Review.ACS Omega2022https://conductscience.org/library/papers/36278104PubMed

Download CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CALR811PubTator's text mininghttps://conductscience.org/library/genes/811NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
HMGB13146PubTator's text mininghttps://conductscience.org/library/genes/3146NCBI Gene
ITGAX3687PubTator's text mininghttps://conductscience.org/library/genes/3687NCBI Gene
MMP24313PubTator's text mininghttps://conductscience.org/library/genes/4313NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35547769

GET https://conductscience.org/api/papers/v1/35547769/references?page=2